NASDAQ: ELDN - Eledon Pharmaceuticals, Inc.

六个月盈利: +80.5%
股息率: 0.00%
部门: Healthcare

促销时间表 Eledon Pharmaceuticals, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc.

更多详情
and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2014-09-17
ISIN US28617K1016
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://eledon.com
Цена ао 2.12
每日价格变化: -0.4577% (4.37)
每周价格变化: -0.2294% (4.36)
每月价格变化: +2.11% (4.26)
3个月内价格变化: +74.7% (2.49)
六个月内的价格变化: +80.5% (2.41)
每年价格变化: +141.67% (1.8)
3年内价格变化: -3.12% (4.49)
5年内价格变化: +623.79% (0.601)
10年价格变化: 0% (4.35)
年初以来价格变化: +3.82% (4.19)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 0.4515 10
P/E 0 0
EV/EBITDA -0.7845 0
全部的: 3.75

效率

姓名 意义 年级
ROA, % -32.03 0
ROE, % -48.34 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.009 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 252.28 10
盈利能力 EPS, % -94.55 0
全部的: 6
更多详情

机构 体积 分享, %
BVF Inc. 4326710 17.88
Armistice Capital, LLC 1824000 7.54
Vanguard Group Inc 674520 2.79
Woodline Partners LP 603993 2.5
Ensign Peak Advisors, Inc 443001 1.83
CM Management, LLC 234803 0.97
Geode Capital Management, LLC 176039 0.73
Royal Bank of Canada 158207 0.65
Renaissance Technologies, LLC 61973 0.26
JMAC Enterprises LLC 58041 0.24

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.02284 17.09 1.54048
Dimensional U.S. Targeted Value ETF 0.00028 26.01 1.93487
Dimensional U.S. Core Equity 2 ETF 0.00015 30.76 1.47098



导师 职称 支付 出生年份
Dr. David-Alexandre C. Gros M.D., Ph.D. CEO & Non Independent Director 807.96k 1972 (53 年)
Dr. Steven N. Perrin Ph.D. President, Chief Scientific Officer & Non Independent Director 603.9k 1966 (59 年)
Mr. Paul Sean Little Chief Financial Officer 611.71k 1965 (60 年)
Mr. John Herberger Vice President of Technical Operations N/A
Mr. Bryan E. Smith J.D. General Counsel, Corporate Secretary & Chief Compliance Officer 377.14k 1980 (45 年)
Dr. David Hovland Ph.D. Chief Regulatory Officer N/A
Dr. Eliezer Katz F.A.C.S., FACS, M.D. Chief Medical Officer N/A

地址: United States, Irvine. CA, 19900 MacArthur Boulevard - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://eledon.com